Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Laboratorio Farmaceutico Erfo SpAMIL:ERFO 64 3-Year Share Buyback Ratio is 1.80 as of Dec. 2025, which is 9% above its 10-year median of 1.65. GuruFocus rates MIL:ERFO with a GF Score™ of 64/100 and a GF Value™ of €2.17 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 958 Consumer Packaged Goods companies, Laboratorio Farmaceutico Erfo SpA ranks better than 91.34% on this metric.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Laboratorio Farmaceutico Erfo SpA's current 3-Year Share Buyback Ratio was 1.80%.
The historical rank and industry rank for Laboratorio Farmaceutico Erfo SpA's 3-Year Share Buyback Ratio or its related term are showing as below:
MIL:ERFO'
s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: 0 Med: 1.65 Max: 2
Current: 1.8
During the past 7 years, Laboratorio Farmaceutico Erfo SpA's highest 3-Year Share Buyback Ratio was 2.00%. The lowest was 0.00%. And the median was 1.65%.
MIL:ERFO's 3-Year Share Buyback Ratio is ranked better than 91.34% of 958
companies
in the Consumer Packaged Goods industry
Industry Median: -0.75
vs MIL:ERFO: 1.80
Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) 3-Year Share Buyback Ratio Explanation
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Laboratorio Farmaceutico Erfo SpA 3-Year Share Buyback Ratio Related Terms
MIL:ERFO vs KHC, GIS, MKC: 3-Year Share Buyback Ratio Comparison
For the Packaged Foods subindustry, Laboratorio Farmaceutico Erfo SpA's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Laboratorio Farmaceutico Erfo SpA 3-Year Share Buyback Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Laboratorio Farmaceutico Erfo SpA's 3-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Laboratorio Farmaceutico Erfo SpA's 3-Year Share Buyback Ratio falls into.
Laboratorio Farmaceutico Erfo SpA 3-Year Share Buyback Ratio Calculation
This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 3-Year Share Buyback Ratio of 1.80 mean?
Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) has a 3-Year Share Buyback Ratio of 1.80 as of Dec. 2025. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Laboratorio Farmaceutico Erfo SpA and its competitors. This is near median its historical median of 1.65. According to the industry distribution chart, Laboratorio Farmaceutico Erfo SpA ranks #83 out of 958 companies in the Consumer Packaged Goods industry, placing it in the top 8.7%.
Is Laboratorio Farmaceutico Erfo SpA's 3-Year Share Buyback Ratio too high?
Laboratorio Farmaceutico Erfo SpA's current 3-Year Share Buyback Ratio of 1.80 is near median its 10-year median of 1.65. Based on the distribution chart, Laboratorio Farmaceutico Erfo SpA ranks #83 out of 958 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Laboratorio Farmaceutico Erfo SpA has a GF Score™ of 64/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Laboratorio Farmaceutico Erfo SpA's 3-Year Share Buyback Ratio compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Laboratorio Farmaceutico Erfo SpA ranks #83 out of 958 companies for 3-Year Share Buyback Ratio. This places Laboratorio Farmaceutico Erfo SpA in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Share Buyback Ratio for a Consumer Packaged Goods company?
A good 3-Year Share Buyback Ratio depends on the Consumer Packaged Goods industry context. However, 3-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Share Buyback Ratio mean?
A high 3-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Laboratorio Farmaceutico Erfo SpA and its competitors. Laboratorio Farmaceutico Erfo SpA's current 3-Year Share Buyback Ratio is 1.80, which is near median its own 10-year median of 1.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Laboratorio Farmaceutico Erfo SpA stock overvalued right now?
Based on GuruFocus' analysis, Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) is currently considered Significantly Undervalued. The stock's GF Value™ is €2.17, compared to a current price of €1.15 — trading 47% below its estimated fair value. The current 3-Year Share Buyback Ratio is 1.80, which is near median its 10-year median of 1.65. Laboratorio Farmaceutico Erfo SpA's overall GF Score™ is 64/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Share Buyback Ratio calculated?
3-Year Share Buyback Ratio is calculated from a company's financial statements. For Laboratorio Farmaceutico Erfo SpA (MIL:ERFO), the current 3-Year Share Buyback Ratio is 1.80 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) Overvalued in 2026?
Based on GuruFocus' analysis, Laboratorio Farmaceutico Erfo SpA stock appears to be undervalued.
The current stock price of €1.15 is trading 47% below its estimated GF Value™ of €2.17.
GuruFocus considers Laboratorio Farmaceutico Erfo SpA to be Significantly Undervalued.
Key valuation signals for MIL:ERFO:
3-Year Share Buyback Ratio: 1.80 (near median its 10-year median of 1.65)
GF Value™: €2.17 vs. price of €1.15 (47% below fair value)
No single metric tells the full story. See the MIL:ERFO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Laboratorio Farmaceutico Erfo SpA operates in the nutraceutical sector. The company specializes in formulating and producing food supplements and natural medicines in different forms such as liquids, powders, granules, tablets, and soft gels. Geographically, the company generates a majority of its revenue from Italy followed by Spain, France, Belgium, and other countries.
64GF Score
Get the complete analysis for MIL:ERFO
3-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:ERFO has been successfully added to your 
